Malononitrilamides: a new strategy of immunosuppression for allo- and xenotransplantation.
Schorlemmer
H
H
Research Laboratories Hoechst Marion Roussel, Pharma Research Werk Kalle-Albert, Wiesbaden, Germany.
Bartlett
R
R
Kurrle
R
R
D000814:Aniline Compounds / Q000627:therapeutic use*; D000818:Animals; D015551:Autoimmunity; D003437:Crotonates; D006084:Graft Rejection / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D006885:Hydroxybutyrates / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000276:immunology; D009570:Nitriles; D016038:Skin Transplantation / Q000276:immunology; D014052:Toluidines; D014183:Transplantation, Heterologous / Q000276:immunology*; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous / Q000276:immunology*
D000814:Aniline Compounds; D003437:Crotonates; D006885:Hydroxybutyrates; D007166:Immunosuppressive Agents; D009570:Nitriles; D014052:Toluidines; C527525:teriflunomide